Investment: $250,000
Investment: $250,000
Moleculera Labs, Inc. is a revenue-generating biotechnology company focused on diagnosing neuropsychiatric disorders in children and adults. Moleculera’s COLA/CLIA accredited clinical laboratory performs tests that direct specialized treatment for neuropsychiatric disorders caused by an infection-triggered immune system dysfunction. This infection-triggered immune dysfunction mechanism, is an emerging area of medicine that may prove to account for a whole host of chronic and debilitating disorders that have been previously unresponsive to symptomatic medical treatments.
www.moleculeralabs.com
Investment: $250,000
SendaRide provides customized non-emergency medical transport for the healthcare industry through use of an online technology platform. SendaRide technology provides hospitals, providers, health plans, independent living centers and family members the ability to book on-demand and scheduled transportation for someone else.
www.moleculeralabs.com
Investment: $250,000
Simergent is developing a home dialysis system which delivers therapy to a sleeping patient each night. Our automated peritoneal dialysis (APD) device focuses on specific needs for dialysis patients. It supports faster training with fewer nursing staff using a color touch screen. Our technology enables our dialysis device cost to be up to 85% less expensive than traditional home devices, allowing the home nocturnal dialysis market to save billions in healthcare costs, while delivering safe and effective therapy more quickly than currently available devices.
www.moleculeralabs.com
Investment: $250,000
Moleculera Labs, Inc. is a revenue-generating biotechnology company focused on diagnosing neuropsychiatric disorders in children and adults. Moleculera’s COLA/CLIA accredited clinical laboratory performs tests that direct specialized treatment for neuropsychiatric disorders caused by an infection-triggered immune system dysfunction. This infection-triggered immune dysfunction mechanism, is an emerging area of medicine that may prove to account for a whole host of chronic and debilitating disorders that have been previously unresponsive to symptomatic medical treatments.
www.moleculeralabs.com
840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
100 S Cincinnati Ave, 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592